Contraception News and Research

Latest Contraception News and Research

Opinions: Family planning; U.S. food aid

In his latest New York Times column, Nicholas Kristof writes about the "unavailability of birth control in many poor countries," noting some experiences from a recent trip to Africa.

24 May 2010

Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Results of two Phase II trials evaluating ALIMTA (pemetrexed for injection) in combination with a platinum chemotherapy and radiation for patients with locally advanced non-small cell lung cancer will be presented by Eli Lilly and Company at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Ill., on June 6, 2010.

21 May 2010

Scidev.Net reports on developing country health care providers, scientists access to research

SciDev.Net reports on two recent studies published in the Canadian Medical Association Journal which look at how frequently health care providers and researchers in developing countries access research-based evidence.

18 May 2010

World Bank announces five-year plan to reduce maternal deaths, fertility rates in 58 low-income countries

During the release of its five-year plan to help drive down high maternal death and fertility rates in low-income countries, the World Bank on Tuesday said "that family planning and other reproductive health services have fallen off the radar of many governments, donors and aid agencies," Reuters reports.

13 May 2010

Merck hosts R&D and Business Briefing

Merck & Co., Inc. today hosted its first R&D and Business Briefing since the completion of the Merck and Schering-Plough merger. The event included a comprehensive review of the company's late-stage pipeline, as well as the company's commercial strategy and progress made in the integration of Merck's worldwide operations.

12 May 2010

UNC-CH awarded $100,000 Grand Challenges Explorations grant for study of ultrasound as a contraceptive

The University of North Carolina at Chapel Hill has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by James Tsuruta, PhD, and Paul Dayton, PhD, titled "Ultrasound as a long-term, reversible contraceptive."

11 May 2010

Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA

Ferring Pharmaceuticals today announced an agreement that will expand its Women's Health product portfolio with the acquisition of the global rights to Xanodyne Pharmaceutical's LYSTEDA™ (tranexamic acid), a first-in-class, non-hormonal therapy indicated specifically for treatment of women with cyclic heavy menstrual bleeding (HMB).

10 May 2010

Study examines social pressures, attitudes on pregnancy

For years, a widely held assumption was that women of childbearing age fell neatly into two camps: those trying to have children, and those not trying to have children.

7 May 2010

FDA approves new oral contraceptive Natazia

The U.S. Food and Drug Administration today approved Natazia, a combination hormonal tablet for use as an oral contraceptive.

7 May 2010

LA BioMed receives $1.5M in grant to study contraceptive for men

As the birth control pill marks its 50th birthday this month, Los Angeles Biomedical Research Institute announced today that it has received $1.5 million in grant funding to study a contraceptive for men that uses a combination of two hormonal gels applied to the skin of the arm and abdomen.

4 May 2010

Women taking hormonal contraceptives are at highest risk of FSD: Study

Women taking non-oral and oral hormonal contraceptives were at highest risk of Female Sexual Dysfunction, according to a study of female German medical students published today in The Journal of Sexual Medicine. Interestingly, women taking non-hormonal contraceptives were at lowest risk for FSD, more than women not using any contraceptive.

4 May 2010

Opinions: Malaria bed net concerns; Catholic Church's humanitarian work; Abortion, global health; Foreign aid reform; Canada's G8 initiative

"To date, millions of dollars from international agencies, NGOs and USAID have been spent to get treated nets into the hands of impoverished, sub-Saharan Africans [to prevent malaria]. ... But, as even the staunchest advocate will admit, the treated nets were not designed with the cultural preferences of the rural African villager in mind," Sonia Shah, author of upcoming book about malaria, writes in a Los Angeles Times opinion piece.

4 May 2010

Canadian leaders focus on hunger, disease prevention at G8 meeting

G8 countries should make use of low-cost, effective tools to prevent hunger, disease and premature deaths among women and children in developing countries, Bev Oda, Canada's international cooperation minister, said on Tuesday at the opening of a meeting of G8 development ministers in Halifax, the Toronto Sun reports (Payton, 4/27).

29 Apr 2010

Canadian government says Canada's G8 maternal, child health plan will not include abortion

Canada on Monday at a meeting of G8 development ministers in Halifax, Canada, said its maternal and child health initiative, which is expected to be a "centerpiece issue" at the G8 summit in late June, will not include funding for abortion, the Associated Press/Washington Post (Gillies, 4/26).

28 Apr 2010

Recent releases in Global Health

"What is still needed [to fight malaria] is the only tool that has ever truly conquered any infectious disease: an effective and affordable vaccine. And here, the global malaria community has been too complacent," a Lancet editorial asserts in an article highlighting achievements and drawbacks in attempting to provide universal access to malaria prevention and treatment.

24 Apr 2010

Research reveals demand for over-the-counter oral contraceptives in the US

American women who live along the U.S.-Mexico border frequently buy over-the-counter oral contraceptives from Mexican pharmacies because they don't need a prescription and can send a friend to pick up the pills, according to a study by researchers from two University of Texas campuses and Ibis Reproductive Health.

15 Apr 2010

Women's perceptions of sexual function after gynecologic surgery

Most women scheduled for gynecologic surgery to address noncancerous symptoms said in a recently published survey that they were not worried about the effects of the procedure on their sex lives.

13 Apr 2010

UNFPA: Global financial crisis should not block further investments in health, human well-being

The global financial crisis should not be allowed to prevent further investments in health and human well-being, said Thoraya Ahmed Obaid, Executive Director of UNFPA, the United Nations Population Fund. The lack of such social investment, she warned, will be most acutely felt in the poorest countries, and will most severely impact those who are socially and economically the most underprivileged—particularly poor women and girls.

13 Apr 2010

Health insurance customers in California, Mass. await decisions about premium increases

Thousands of worried Californians who buy individual insurance policies from Anthem Blue Cross will soon learn whether they face rate increases of up to 39% that were put on hold for two months amid a public outcry that helped revive national healthcare legislation.

13 Apr 2010

Gilead Sciences doses first patient in Quad Phase III clinical program

Gilead Sciences, Inc. today announced that it has dosed the first patient in the Phase III clinical program evaluating its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat (formerly GS 9350), emtricitabine and tenofovir disoproxil fumarate.

13 Apr 2010

Contraception News and Research

Latest Contraception News and Research

Opinions: Family planning; U.S. food aid

Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Scidev.Net reports on developing country health care providers, scientists access to research

World Bank announces five-year plan to reduce maternal deaths, fertility rates in 58 low-income countries

Merck hosts R&D and Business Briefing

UNC-CH awarded $100,000 Grand Challenges Explorations grant for study of ultrasound as a contraceptive

Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA

Study examines social pressures, attitudes on pregnancy

FDA approves new oral contraceptive Natazia

LA BioMed receives $1.5M in grant to study contraceptive for men

Women taking hormonal contraceptives are at highest risk of FSD: Study

Opinions: Malaria bed net concerns; Catholic Church's humanitarian work; Abortion, global health; Foreign aid reform; Canada's G8 initiative

Canadian leaders focus on hunger, disease prevention at G8 meeting

Canadian government says Canada's G8 maternal, child health plan will not include abortion

Recent releases in Global Health

Research reveals demand for over-the-counter oral contraceptives in the US

Women's perceptions of sexual function after gynecologic surgery

UNFPA: Global financial crisis should not block further investments in health, human well-being

Health insurance customers in California, Mass. await decisions about premium increases

Gilead Sciences doses first patient in Quad Phase III clinical program

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Contraception News and Research

Latest Contraception News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in